Your browser doesn't support javascript.
loading
Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure.
Chowdhury, Shahryar M; Graham, Eric M; Taylor, Carolyn L; Savage, Andrew; McHugh, Kimberly E; Gaydos, Stephanie; Nutting, Arni C; Zile, Michael R; Atz, Andrew M.
Afiliação
  • Chowdhury SM; Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
  • Graham EM; Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
  • Taylor CL; Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
  • Savage A; Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
  • McHugh KE; Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
  • Gaydos S; Division of Cardiology Department of Medicine Medical University of South Carolina Charleston SC.
  • Nutting AC; Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
  • Zile MR; Division of Cardiology Department of Medicine Medical University of South Carolina Charleston SC.
  • Atz AM; Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
J Am Heart Assoc ; 11(2): e024095, 2022 01 18.
Article em En | MEDLINE | ID: mdl-35023347
ABSTRACT
Background Heart failure phenotyping in single-ventricle Fontan patients is challenging, particularly in patients with normal ejection fraction (EF). The objective of this study was to identify Fontan patients with abnormal diastolic function, who are high risk for heart failure with preserved ejection fraction (HFpEF), and characterize their cardiac mechanics, exercise function, and functional health status. Methods and Results Data were obtained from the Pediatric Heart Network Fontan Cross-sectional Study database. EF was considered abnormal if <50%. Diastolic function was defined as abnormal if the diastolic pressurevolume quotient (lateral Ee'/end-diastolic volume) was >90th percentile (≥0.26 mL-1). Patients were divided into controls=normal EF and diastolic function; systolic dysfunction (SD) = abnormal EF with normal diastolic function; diastolic dysfunction (DD) = normal EF with abnormal diastolic pressurevolume quotient. Exercise function was quantified as percent predicted peak VO2. Physical Functioning Summary Score (FSS) was reported from the Child Health Questionnaire. A total of 239 patients were included, 177 (74%) control, 36 (15%) SD, and 26 (11%) DD. Median age was 12.2 (5.4) years. Arterial elastance, a measure of arterial stiffness, was higher in DD (3.6±1.1 mm Hg/mL) compared with controls (2.5±0.8 mm Hg/mL), P<0.01. DD patients had lower predicted peak VO2 compared with controls (52% [20] versus 67% [23], P<0.01). Physical FSS was lower in DD (45±13) and SD (44±13) compared with controls (50±7), P<0.01. Conclusions Fontan patients with abnormal diastolic function and normal EF have decreased exercise tolerance, decreased functional health status, and elevated arterial stiffness. Identification of patients at high risk for HFpEF is feasible and should be considered when evaluating Fontan patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnica de Fontan / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnica de Fontan / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article